Literature DB >> 6472366

Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.

D T O'Connor, K N Bernstein.   

Abstract

Chromogranin A is the major soluble protein stored and secreted by exocytosis, along with catecholamines, from vesicles in the adrenal medulla and sympathetic nerves. We investigated the possible use of chromogranin A as a probe of exocytotic sympathoadrenal activity, by developing a radioimmunoassay for chromogranin A purified from pheochromocytoma vesicles. In 18 normal recumbent men chromogranin A was present in plasma at a concentration of 129 +/- 12 ng per milliliter. The concentration varied with physiologic, pharmacologic, and pathologic changes in sympathoadrenal activity. It rose with standing and fell with recumbency, though it was not perturbed by brief dynamic exercise. It rose during brief vasodilation and fell during stimulation of nonexocytotic catecholamine release by tyramine and during ganglionic blockade. The plasma concentration of chromogranin A was elevated in 11 patients with pheochromocytoma (1614 +/- 408 ng per milliliter). The mean plasma half-life was 18.4 minutes. We conclude that both resting and activated sympathoadrenal tone in normal persons, as well as catecholamine secretion by pheochromocytoma, are at least in part exocytotic in mechanism and that chromogranin A may be a useful probe of exocytotic sympathoadrenal activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472366     DOI: 10.1056/NEJM198409203111204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  47 in total

Review 1.  Biochemistry of the chromogranin A protein family.

Authors:  J P Simon; D Aunis
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

Review 2.  The use of salivary biomarkers in occupational and environmental medicine.

Authors:  David Soo-Quee Koh; Gerald Choon-Huat Koh
Journal:  Occup Environ Med       Date:  2007-03       Impact factor: 4.402

3.  Undegraded chromogranin A is present in serum and enters the endocytotic lysosomal pathway in kidney.

Authors:  R Weiler; H J Steiner; R Fischer-Colbrie; K W Schmid; H Winkler
Journal:  Histochemistry       Date:  1991

4.  Plasma gut hormone levels in 37 patients with pheochromocytomas.

Authors:  A I Vinik; B Shapiro; N W Thompson
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 5.  Chromogranin A as a crucial factor in the sorting of peptide hormones to secretory granules.

Authors:  Salah Elias; Charlène Delestre; Maite Courel; Youssef Anouar; Maite Montero-Hadjadje
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

Review 6.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

7.  Salivary function impairment in type 2 Diabetes patients associated with concentration and genetic polymorphisms of chromogranin A.

Authors:  Evelyn Mikaela Kogawa; Daniela Corrêa Grisi; Denise Pinheiro Falcão; Ingrid Aquino Amorim; Taia Maria Berto Rezende; Izabel Cristina Rodrigues da Silva; Osmar Nascimento Silva; Octávio Luiz Franco; Rivadávio Fernandes Batista de Amorim
Journal:  Clin Oral Investig       Date:  2016-01-11       Impact factor: 3.573

Review 8.  Chromogranin A and derived peptides in health and disease.

Authors:  Y Peng Loh; Yong Cheng; Sushil K Mahata; Angelo Corti; Bruno Tota
Journal:  J Mol Neurosci       Date:  2012-03-03       Impact factor: 3.444

9.  Biochemical prognostic indicators for pancreatic neuroendocrine tumors and small bowel neuroendocrine tumors.

Authors:  Christine S Landry; Keith Cavaness; Scott Celinski; John Preskitt
Journal:  Gland Surg       Date:  2014-11

10.  Morphological and molecular changes of the myocardium after left ventricular mechanical support.

Authors:  Hideo A Baba; Jeremias Wohlschlaeger
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.